MAP3K1 mutations confer tumor immune heterogeneity in hormone receptor–positive HER2-negative breast cancerYuwen Cai(Fudan University), Ke‐Da Yu(Fudan University)Journal of Clinical InvestigationNovember 12, 202410.1172/jci183656Cited by 12SaveCiteExport RISWatch citationsRelated PapersCombined Single‐Cell and Spatial Transcriptomics Reveal the Metabolic Evolvement of Breast Cancer during Early Dissemination|Advanced Science|2023|157